Filtros de búsqueda

Lista de obras de Suzanne R Hayman

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published on June 2010

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

artículo científico publicado en 2011

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

artículo científico publicado en 2013

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

artículo científico publicado en 2008

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

scientific article published on 14 April 2020

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

artículo científico publicado en 2006

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

artículo científico publicado en 2012

Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis

artículo científico publicado en 2011

Amyloidosis

artículo científico publicado en 2005

Amyloidosis: diagnosis and management

artículo científico publicado en 2005

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma.

artículo científico publicado en 2018

Angiogenesis in Waldenstrom's macroglobulinemia

artículo científico publicado en 2003

Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions

artículo científico publicado en 2008

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

artículo científico publicado en 2010

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.

artículo científico publicado en 2008

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

artículo científico publicado en 2010

Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative

artículo científico publicado en 2008

Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency

artículo científico publicado en 2015

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.

artículo científico publicado en 2008

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

artículo científico publicado en 2016

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

artículo científico publicado en 2020

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy

artículo científico publicado en 2010

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

artículo científico publicado en 2011

Clinical characteristics and outcomes in biclonal gammopathies

artículo científico publicado en 2016

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma ⬇️

artículo científico publicado en 2010

Clinical implication of centrosome amplification in plasma cell neoplasm

artículo científico publicado en 2005

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

artículo científico publicado en 2009

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

artículo científico publicado en 2017

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

artículo científico publicado en 2013

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

artículo científico publicado en 2005

Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial

artículo científico publicado en 2005

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

artículo científico publicado en 2002

Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.

artículo científico publicado en 2018

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

artículo científico publicado en 2010

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization

artículo científico publicado en 2012

Current status of stem cell transplantation for multiple myeloma

artículo científico publicado en 2005

Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma

artículo científico publicado en 2006

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

artículo científico publicado en 2019

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

artículo científico publicado en 2018

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

scientific article published on 21 October 2019

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

artículo científico

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.

artículo científico publicado en 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients.

artículo científico publicado en 2016

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

artículo científico publicado en 2019

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

artículo científico publicado en 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

artículo científico publicado en 2010

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

article by Eli Muchtar et al published 12 March 2018 in Amyloid

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

artículo científico publicado en 2010

Domino liver transplantation as a cause of acquired familial amyloid polyneuropathy

Doppler Myocardial Imaging Compared to Standard Two-Dimensional and Doppler Echocardiography for Assessment of Diastolic Function in Patients With Systemic Amyloidosis

artículo científico publicado en 2009

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis

artículo científico publicado en 2005

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

artículo científico publicado en 2011

Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response

artículo científico publicado en 2007

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

artículo científico publicado en 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

artículo científico publicado en 2017

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

artículo científico publicado en 2011

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

artículo científico publicado en 2017

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

artículo científico publicado en 2020

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

scientific article published on 13 July 2012

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

scientific article published on 11 July 2019

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.

artículo científico publicado en 2016

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system

artículo científico publicado en 2005

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

artículo científico publicado en 2017

Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma

scientific article published on 29 September 2011

High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma

artículo científico publicado en 2006

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

artículo científico publicado en 2011

Hypertension in pregnancy: an emerging risk factor for cardiovascular disease

artículo científico publicado en 2007

Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia

artículo científico publicado en 2009

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

artículo científico publicado en 2009

IgM Amyloidosis: Clinical Features in Therapeutic Outcomes ⬇️

artículo científico publicado el 1 de febrero de 2011

Immunoglobulin D amyloidosis: a distinct entity

artículo científico publicado en 2011

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias

scientific article published on 02 September 2014

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

artículo científico publicado en 2016

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics.

artículo científico publicado en 2017

Impact of acquired del(17p) in multiple myeloma

artículo científico publicado en 2019

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

scientific article published on 23 July 2019

Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2009

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

artículo científico publicado en 2018

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

artículo científico publicado en 2017

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

artículo científico publicado en 2020

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.

artículo científico publicado en 2016

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

artículo científico publicado en 2017

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

artículo científico publicado en 2009

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of continued response after autologous stem cell transplantation for multiple myeloma

artículo científico publicado en 2013

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

artículo científico publicado en 2013

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

artículo científico publicado en 2017

Improved survival in multiple myeloma and the impact of novel therapies

artículo científico publicado en 2007

In vivo and in silico studies on single versus multiple transplants for multiple myeloma.

artículo científico publicado en 2007

Incidence and prognosis of acute heart failure in the thrombotic microangiopathies

artículo científico publicado en 2005

Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice

scientific article published on 25 May 2020

Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation

artículo científico publicado en 2013

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

artículo científico publicado en 2018

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

artículo científico publicado en 2009

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

artículo científico publicado en 2016

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

artículo científico publicado en 2015

Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study

scholarly article by Joseph Mikhael et al published 29 August 2018 in Blood Cancer Journal

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

artículo científico publicado en 2009

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

artículo científico publicado en 2011

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

artículo científico publicado en 2012

Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience

artículo científico publicado en 2016

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy

artículo científico publicado en 2014

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.

artículo científico publicado en 2008

Long-term outcome of autologous stem cell transplantation in light chain deposition disease

artículo científico publicado en 2008

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

artículo científico publicado en 2016

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

artículo científico publicado en 2012

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

artículo científico publicado en 2020

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation

artículo científico publicado en 2011

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

artículo científico publicado en 2007

Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

artículo científico publicado en 2010

Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia

artículo científico publicado en 2014

Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms.

artículo científico publicado en 2013

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

artículo científico publicado en 2017

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

artículo científico

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

artículo científico publicado en 2006

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

artículo científico publicado en 2020

Methodological differences account for inconsistencies in reported free VEGF concentrations in pregnant rats

artículo científico publicado en 2014

Multiple myeloma after kidney transplantation

artículo científico publicado en 2014

Myelomatous Involvement of the Central Nervous System

artículo científico publicado en 2016

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2016

Natural history of amyloidosis isolated to fat and bone marrow aspirate.

artículo científico publicado en 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study

artículo científico publicado en 2016

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

artículo científico publicado en 2008

Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.

artículo científico publicado en 2014

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

artículo científico publicado en 2019

Outcomes of patients with POEMS syndrome treated initially with radiation

artículo científico publicado en 2013

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

artículo científico publicado en 2016

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

artículo científico publicado en 2015

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2019

Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis

artículo científico publicado en 2020

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

artículo científico publicado en 2017

POEMS syndrome and paraproteinemic syndromes: management and follow-up

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

artículo científico publicado en 2008

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia

artículo científico publicado en 2010

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study

artículo científico publicado en 2013

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

artículo científico publicado en 2009

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

artículo científico publicado en 2011

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

artículo científico publicado en 2017

Pre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular disease

artículo científico publicado en 2008

Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study

artículo científico publicado en 2008

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

artículo científico publicado en 2015

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

artículo científico publicado en 2017

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

artículo científico publicado en 2017

Primary systemic amyloidosis presenting with asymmetric multiple mononeuropathies

artículo científico publicado en 2010

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

artículo científico publicado en 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis.

artículo científico publicado en 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

artículo científico publicado en 2019

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

artículo científico publicado en 2016

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method

scientific article published on 08 January 2019

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

artículo científico publicado en 2011

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

artículo científico publicado en 2018

Relationship Between Depth of Response and Outcome in Multiple Myeloma

scientific article published on 01 November 2007

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

artículo científico publicado en 2003

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

artículo científico publicado en 2012

Revisiting complete response in light chain amyloidosis

scientific article published on 26 November 2019

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

artículo científico publicado en 2018

Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

artículo científico publicado en 2018

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation

artículo científico publicado en 2017

Serum M-spike and transplant outcome in patients with multiple myeloma.

artículo científico publicado en 2007

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome

artículo científico publicado en 2010

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

artículo científico publicado en 2010

Serum uric acid: novel prognostic factor in primary systemic amyloidosis

artículo científico publicado en 2008

Severity of Baseline Proteinuria Predicts Renal Response in Immunoglobulin Light Chain-Associated Amyloidosis after Autologous Stem Cell Transplantation

artículo científico publicado en 2007

Smoldering multiple myeloma requiring treatment: time for a new definition?

artículo científico publicado en 2013

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

artículo científico publicado en 2015

Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis

artículo científico publicado en 2016

Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction

artículo científico publicado en 2010

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation

artículo científico publicado en 2005

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

artículo científico publicado en 2016

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2013

Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis

artículo científico publicado en 2012

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

artículo científico publicado en 2006

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

artículo científico publicado en 2015

The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma

artículo científico publicado en 2019

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

artículo científico publicado en 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

artículo científico publicado en 2016

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor

scientific article published on 23 January 2020

The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome

scientific article published on 31 August 2011

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

artículo científico publicado en 2018

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

artículo científico publicado en 2009

Transplantation for IgM amyloidosis and IgM myeloma

artículo científico publicado en 2009

Transplantation for amyloidosis

artículo científico publicado en 2007

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

artículo científico

Treatment of immunoglobulin light chain (primary or AL) amyloidosis.

artículo científico publicado en 2011

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

artículo científico publicado en 2007

Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapy

artículo científico publicado en 2012

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

artículo científico publicado en 2017

Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic

artículo científico

Trends and outcomes of modern staging of solitary plasmacytoma of bone

artículo científico publicado en 2012

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

artículo científico publicado en 2014

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

artículo científico publicado en 2012

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.

artículo científico publicado en 2008

Two types of amyloidosis presenting in a single patient: a case series

artículo científico publicado en 2019

Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases

artículo científico publicado en 2012

Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignancies

artículo científico publicado en 2014

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

artículo científico publicado en 2020

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2018

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

artículo científico publicado en 2020

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

artículo científico publicado en 2020

VEGF inhibition, hypertension, and renal toxicity

scientific article published on August 2012

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Waldenström macroglobulinaemia.

artículo científico publicado en 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda